Zengying Liu, Ningxin Zhang, Bin Zhou, & Yan Xu. (2022). Commentary: Dapagliflozin Mediates Plin5/PPARα Signaling Axis to Attenuate Cardiac Hypertrophy. Frontiers Media S.A..
Chicago Style (17th ed.) CitationZengying Liu, Ningxin Zhang, Bin Zhou, and Yan Xu. Commentary: Dapagliflozin Mediates Plin5/PPARα Signaling Axis to Attenuate Cardiac Hypertrophy. Frontiers Media S.A., 2022.
MLA (9th ed.) CitationZengying Liu, et al. Commentary: Dapagliflozin Mediates Plin5/PPARα Signaling Axis to Attenuate Cardiac Hypertrophy. Frontiers Media S.A., 2022.
Warning: These citations may not always be 100% accurate.